Researchers have identified the human enzyme APEH as a crucial activator of antimalarial prodrugs, paving the way for more ...
Statins, commonly used to lower cholesterol, may significantly reduce the risk of liver cancer in patients with chronic liver disease, a new study suggests.
Fine particulate matter (PM2.5) appears to be associated with skin redness across age groups, according to a study published ...
The adjusted subhazard ratios were 0.67 and 0.78 for HCC and hepatic decompensation, respectively. Further reductions in HCC and hepatic decompensation risks were seen in association with exposure to ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
16 天
MedPage Today on MSNStatin Use Linked With Reduced Risks in Chronic Liver DiseaseStatin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and hepatic decompensation, researchers found. In a cohort of 16,501 individuals ...
Objectives: To prospectively evaluate whether use of statins is associated with the risk of AD, and to determine whether associations differ for lipophilic and hydrophilic statins. Method: 6992 ...
Lipophilic pollutants and nutrients, like dioxins and polyunsaturated fatty acids, may often converge at all aforementioned levels and thus the interactions become more likely. Despite this fact, the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果